Ergoteles’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-187,789	Closed	-$220K	–	1525
2022 Q4	$220K	Sell	187,789 -303,106	-62%	-$355K	0.01%	1034
2022 Q3	$555K	Sell	490,895 -62,738	-11%	-$70.9K	0.02%	715
2022 Q2	$875K	Buy	+553,633	New	+$875K	0.03%	599